Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D M Capuzzi

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
The American Journal of Cardiology|January 23, 1999
Treatment of hyperlipidemia with combined niacin-statin regimensJ R Guyton, D M Capuzzi
Journal of Cardiovascular Pharmacology|January 1, 1984
Inhibition of hepatic cholesterol and triglyceride synthesis by guanabenz acetateD M Capuzzi, W H Cevallos
Current Cardiology Reports|August 16, 2001
Pathophysiology and treatment of the dyslipidemia of insulin resistanceG Cohn, G Valdes, D M Capuzzi
Biochemical and Biophysical Research Communications|June 30, 1993
Binding of thrombospondin to human plasma lipoproteinsA Muraishi, D M Capuzzi, G P Tuszynski
Angiology|November 1, 1996
In situ endothelin in coronary artery diseaseJ I Brody, D M Capuzzi, G B Fink
The American Journal of Cardiology|January 23, 1999
A new extended-release niacin (Niaspan): efficacy, tolerability, and safety in hypercholesterolemic patientsJ M Morgan, D M Capuzzi, J R Guyton
Journal of Cellular Physiology|August 1, 1981
Stimulated secretion of esterified lipids and VLDL by perifused hepatocytesD M Capuzzi, R D Lackman, G G Pietra
Biochemical and Biophysical Research Communications|October 15, 1990
Plasma lipoproteins mediate platelet adhesionM A Kowalska, G P Tuszynski, D M Capuzzi
International Journal of Clinical Pharmacology and Therapeutics|May 1, 1994
Pharmacodynamics of a continuous intravenous infusion of CGP-35126 recombinant human insulin-like growth factor-I (rhIGF-I) on glucose and insulin levels in healthy malesJ M Morgan, A J Piraino, S D Saris, et al.
Current Atherosclerosis Reports|December 21, 2000
Niacin dosing: relationship to benefits and adverse effectsD M Capuzzi, J M Morgan, O A Brusco, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
The American Journal of Cardiology|January 23, 1999
Treatment of hyperlipidemia with combined niacin-statin regimensJ R Guyton, D M Capuzzi
Journal of Cardiovascular Pharmacology|January 1, 1984
Inhibition of hepatic cholesterol and triglyceride synthesis by guanabenz acetateD M Capuzzi, W H Cevallos
Current Cardiology Reports|August 16, 2001
Pathophysiology and treatment of the dyslipidemia of insulin resistanceG Cohn, G Valdes, D M Capuzzi
Biochemical and Biophysical Research Communications|June 30, 1993
Binding of thrombospondin to human plasma lipoproteinsA Muraishi, D M Capuzzi, G P Tuszynski
Angiology|November 1, 1996
In situ endothelin in coronary artery diseaseJ I Brody, D M Capuzzi, G B Fink
The American Journal of Cardiology|January 23, 1999
A new extended-release niacin (Niaspan): efficacy, tolerability, and safety in hypercholesterolemic patientsJ M Morgan, D M Capuzzi, J R Guyton
Journal of Cellular Physiology|August 1, 1981
Stimulated secretion of esterified lipids and VLDL by perifused hepatocytesD M Capuzzi, R D Lackman, G G Pietra
Biochemical and Biophysical Research Communications|October 15, 1990
Plasma lipoproteins mediate platelet adhesionM A Kowalska, G P Tuszynski, D M Capuzzi
International Journal of Clinical Pharmacology and Therapeutics|May 1, 1994
Pharmacodynamics of a continuous intravenous infusion of CGP-35126 recombinant human insulin-like growth factor-I (rhIGF-I) on glucose and insulin levels in healthy malesJ M Morgan, A J Piraino, S D Saris, et al.
Current Atherosclerosis Reports|December 21, 2000
Niacin dosing: relationship to benefits and adverse effectsD M Capuzzi, J M Morgan, O A Brusco, et al.
Pageof 4